Journal Article Summary

The article investigates how individuals with well-treated hypothyroidism respond to liraglutide, a medication used for weight management, compared to those without thyroid disease. This topic is important because hypothyroidism is often linked to weight gain, and while standard treatments like levothyroxine can restore hormone levels, they do not significantly promote weight loss. Understanding the effectiveness of obesity medications in this population can help healthcare providers better support patients struggling with weight management.

In this retrospective case-control study, researchers analyzed data from adults with obesity who were treated with liraglutide at a weight management center between 2017 and 2022. The study included 53 patients with hypothyroidism on stable levothyroxine therapy and 145 matched controls without thyroid disease. After an average follow-up of 10 months, both groups experienced similar weight loss, with the hypothyroid group losing an average of 10.8% of their body weight compared to 8.9% in the control group. Additionally, the proportion of weight loss attributed to fat-free mass was comparable between the two groups.

While the findings are promising, the study has limitations, including its retrospective design, which may introduce biases and confounding factors. Important variables such as dietary habits and physical activity were not assessed, which could influence weight loss outcomes. Patients should discuss their weight management strategies and any potential adjustments to their levothyroxine dosage with their healthcare providers, especially if they are considering or currently using liraglutide for weight loss.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Chukir Tariq, Yaghmour Mohammad, Almutairi Turki, Chagoury Odette, Taheri Shahrad, Rad Afagh Hassanzadeh, Rad Afagh Hassanzadeh, Rad Afagh Hassanzadeh, et al.. Weight and body composition outcomes with liraglutide in individuals with well-treated hypothyroidism: A retrospective case-control study. PLOS One 2025. DOI: 10.1371/journal.pone.0332091. PMID: 40934243. PMCID: PMC12425291.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]